Diabetes Insipidus
📧 Sign up to get email alerts when something new happens for Diabetes Insipidus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency [NA]
A clinical trial update examining how plasma oxytocin responds to oral estrogens in healthy controls and individuals with vasopressin defici…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
This update describes an international registry and clinical study for Wolfram syndrome and WFS1-related disorders, which is currently recru…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls [Phase 2]
Phase 2 clinical trial investigating intranasal oxytocin for emotion recognition and stress-induced cortisol response in central diabetes in…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Copeptin in the Diagnosis of Post-operative Insipidus Diabetes After Pituitary Surgery [NA]
The trial evaluated copeptin as a diagnostic biomarker for postoperative diabetes insipidus after pituitary surgery; the study status is com…
-
FDA approval · 2024-04-30FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for hydrochlorothiazide filed by Accord Healthcare Inc. under ANDA 202556. The document does not…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-07-21FDA Approved: VASOPRESSIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's supplemental application for Vasopressin under ANDA212944, authorizing changes to the approved generic product.
-
FDA approval · 2022-08-05FDA Approved: VASOPRESSIN — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's original application for a generic vasopressin product.
-
FDA approval · 2022-07-18FDA Approved: VASOPRESSIN — Original Application (Amphastar Pharmaceuticals, Inc.)
FDA approved Amphastar Pharmaceuticals' generic vasopressin product through an Original Application (ANDA). This allows marketing of a vasop…
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: Shared Health Appointments and Reciprocal Enhanced Support
A completed clinical trial investigating shared health appointments and reciprocal enhanced support for Diabetes Insipidus; results posted i…
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Tracking Neurodegeneration in Early Wolfram Syndrome
The clinical trial 'Tracking Neurodegeneration in Early Wolfram Syndrome' (NCT02455414) has completed, sponsored by Washington University Sc…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Use of Copeptin in Diabetes Insipidus
A clinical trial investigating copeptin in diabetes insipidus has completed, with primary polydipsia included as a condition studied.
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Effect of Statin Treatment on Urinary AQP2 (uAQP2/01)
A completed clinical trial investigates the effect of statin treatment on urinary aquaporin-2 (uAQP2).
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study
The CoSIP study evaluated copeptin as a diagnostic and differential diagnostic biomarker for diabetes insipidus; the trial status is complet…
-
FDA approval · 2013-01-25FDA Approved: DESMOPRESSIN ACETATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved an Abbreviated New Drug Application for Desmopressin Acetate from Sun Pharmaceutical Industries, marking a generic product appr…
-
FDA label_change · 2008-04-25FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Bauch & Lomb Incorporated)
FDA approved a supplemental application for Desmopressin Acetate from Bauch & Lomb Incorporated, indicating changes to labeling or related r…
-
FDA approval · 2008-03-11FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Desmopressin Acetate from Apotex Corp., updating the approved generic product. The action formal…